Furthermore, P53 phosphorylation and BAX expression were not suppressed by imatinib pretreatment, further confirming the antiapoptotic effect of C-MYC in Sup-B15, different from that in Ph− B-ALL cells (Fig. 4D). The gene discussed is BAX; the disease is acute lymphoblastic leukemia.